Medtronic expands aortic offering
This article was originally published in Clinica
Medtronic has bulked up its aortic portfolio with the $110m acquisition of Aptus Endosystems, a California company specializing in endovascular aneurysm repair and thoracic endovascular aneurysm repair. Aptus’ Heli-FX and Heli-FX Thoracic EndoAnchor systems feature an endovascular deployed anchor designed to attach a variety of aortic endografts to the native vessel wall, without the need for complicated procedures. The devices are CE marked and US FDA-cleared, and can be used with commercially available stent graft systems, including Medtronic’s Endurant and Valiant stent graft systems. Medtronic said it plans to pursue approval for <10mm>10mm>
You may also be interested in...
This month's edition of Device Debuts includes new product launches from Medtronic, Cochlear, Qualcomm, Titan Spine, Stryker, Philips, Nuance, Nevro, Siemens, Vortex BioSciences, ResMed, Respircardia, and others.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.